Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
Bioorganic & Medicinal Chemistry
|
March 1, 2011
Development of sulfonamide AKT PH domain inhibitors
Ali Md Ahad, Song Zuohe, Lei Du-Cuny, et al.
Leukemia
|
February 1, 2019
Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia
Rong Chen, Mingzhao Zhu, Rajan R Chaudhari, et al.
Cancer Research
|
April 24, 2014
Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein
Zhiyong Ding, Peter German, Shanshan Bai, et al.
Scientific Reports
|
January 18, 2020
Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions
Chiyi Xiong, Yunfei Wen, Jun Zhao, et al.
Nature Communications
|
November 11, 2018
The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance
Fei Han, Chien-Feng Li, Zhen Cai, et al.
Iscience
|
November 2, 2023
Membrane anchoring of the DIRAS3 N-terminal extension permits tumor suppressor function
Xiaowen Liang, Sung Yun Jung, Lon Wolf Fong, et al.
Cancer Research
|
June 4, 2009
In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT
Sylvestor A Moses, M Ahad Ali, Song Zuohe, et al.
Non-Coding RNA
|
September 21, 2018
The Non-Coding RNA Journal Club: Highlights on Recent Papers-6
Hua Xiao, Patrick K T Shiu, Jun Shu, et al.
Cell
|
August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression
Chia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2012
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors
Jose Francisco Islas, Yu Liu, Kuo-Chan Weng, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
Bioorganic & Medicinal Chemistry
|
March 1, 2011
Development of sulfonamide AKT PH domain inhibitors
Ali Md Ahad, Song Zuohe, Lei Du-Cuny, et al.
Leukemia
|
February 1, 2019
Creating novel translation inhibitors to target pro-survival proteins in chronic lymphocytic leukemia
Rong Chen, Mingzhao Zhu, Rajan R Chaudhari, et al.
Cancer Research
|
April 24, 2014
Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein
Zhiyong Ding, Peter German, Shanshan Bai, et al.
Scientific Reports
|
January 18, 2020
Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions
Chiyi Xiong, Yunfei Wen, Jun Zhao, et al.
Nature Communications
|
November 11, 2018
The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance
Fei Han, Chien-Feng Li, Zhen Cai, et al.
Iscience
|
November 2, 2023
Membrane anchoring of the DIRAS3 N-terminal extension permits tumor suppressor function
Xiaowen Liang, Sung Yun Jung, Lon Wolf Fong, et al.
Cancer Research
|
June 4, 2009
In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT
Sylvestor A Moses, M Ahad Ali, Song Zuohe, et al.
Non-Coding RNA
|
September 21, 2018
The Non-Coding RNA Journal Club: Highlights on Recent Papers-6
Hua Xiao, Patrick K T Shiu, Jun Shu, et al.
Cell
|
August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression
Chia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 25, 2012
Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors
Jose Francisco Islas, Yu Liu, Kuo-Chan Weng, et al.
Page
of 9